Sample-Size Formula for the Proportional-Hazards Regression Model

From MaRDI portal
Revision as of 14:40, 4 February 2024 by Import240129110113 (talk | contribs) (Created automatically from import240129110113)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Publication:3332138

DOI10.2307/2531021zbMath0543.62096OpenAlexW1988262403WikidataQ47253781 ScholiaQ47253781MaRDI QIDQ3332138

David A. Schoenfeld

Publication date: 1983

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: https://semanticscholar.org/paper/3ccf2bf9eff96fda5ae8087298a1ec540012bfce



Related Items

Sample size calculation for a proportional hazards mixture cure model with nonbinary covariates, Empirical Bayes estimators in hierarchical models with mixture priors, Testing equivalence of survival before but not after end of follow-up, Sample size calculation for clustered survival data under subunit randomization, Minimum Size Survival Analysis Sampling Plans for Comparing Multiple Treatment Groups to a Single Control Group, Heterogeneous treatment effects in stratified clinical trials with time‐to‐event endpoints, Group sequential testing for cluster randomized trials with time‐to‐event endpoint, Sample size estimation for cancer randomized trials in the presence of heterogeneous populations, Expected Precision of Estimation and Probability of Ruling Out a Hypothesis Based on a Confidence Interval, Design aspects of COVID‐19 treatment trials: Improving probability and time of favorable events, Sample size calculation for two‐arm trials with time‐to‐event endpoint for nonproportional hazards using the concept of Relative Time when inference is built on comparing Weibull distributions, Sample size determination in superiority or non-inferiority clinical trials with time-to-event data under exponential, Weibull and Gompertz distributions, Stratified modestly weighted log‐rank tests in settings with an anticipated delayed separation of survival curves, Analyzing survival data in conjunction with time-dependent surrogate endpoints in clinical trials, Sample size formula for general win ratio analysis, Robust Covariate‐Adjusted Log‐Rank Statistics and Corresponding Sample Size Formula for Recurrent Events Data, Calculating the power or sample size for the logistic and proportional hazards models, Proportional hazards model under ranked set sampling scheme using censored data of coronary heart disease, Estimation of Main Effect When Covariates Have Non-Proportional Hazards, Sample size calculation for paired survival data: a simulation method, The Use of Frailty Hazard Models for Unrecognized Heterogeneity That Interacts with Treatment: Considerations of Efficiency and Power, Sample size calculation for the log-rank tests for multi-arm trials with a control, Sample Size Requirements and Study Duration for Testing Main Effects and Interactions in Completely Randomized Factorial Designs When Time to Event is the Outcome, Sample size calculations for noninferiority trials for time-to-event data using the concept of proportional time, Sample-size calculation and reestimation for a semiparametric analysis of recurrent event data taking robust standard errors into account, A Simulation-Based Evaluation of the Asymptotic Power Formulas for Cox Models in Small Sample Cases